0001209191-17-009057.txt : 20170209
0001209191-17-009057.hdr.sgml : 20170209
20170209160937
ACCESSION NUMBER: 0001209191-17-009057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170207
FILED AS OF DATE: 20170209
DATE AS OF CHANGE: 20170209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: King David John
CENTRAL INDEX KEY: 0001684902
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 17587658
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-07
0
0001339970
aTYR PHARMA INC
LIFE
0001684902
King David John
3545 JOHN HOPKINS COURT
SUITE 250
SAN DIEGO
CA
92121
0
1
0
0
See Remarks
Employee Stock Option (right to buy)
3.30
2017-02-07
4
A
0
65000
0.00
A
2027-03-07
Common Stock
65000
65000
D
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 7, 2017, such that this option will be fully exercisable on February 7, 2021. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
Senior Vice President, Research
Nancy D. Krueger, attorney-in-fact
2017-02-09